U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07253753) titled 'A Study to Evaluate Safety and Dosimetry of [18F]4-FDF, a New PET Imaging Agent for Inflammation' on Nov. 14.
Brief Summary: A standard imaging test used to look for disease in the body is a positron emission tomography (PET) scan. These scans use a small amount of a radioactive substance, called a radiotracer. The most commonly used radiotracer is FDG, which shows us how the body uses glucose (a type of sugar). However, because the brain and heart naturally use a lot of glucose, the images can have background 'noise' making it harder for doctors to see signs of disease in these organs.
NeuCaVis is a new type of radiotracer that is...